Anti-cancer therapy with EGFR inhibitors: factors of prognostic and predictive significance.
Metro
G
G
Bellaria Hospital, Department of Medical Oncology, Bologna, Italy.
Finocchiaro
G
G
Cappuzzo
F
F
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008495:Medical Oncology; D011379:Prognosis
D000911:Antibodies, Monoclonal; D004791:Enzyme Inhibitors; D066246:ErbB Receptors